Clinical Trial

Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors

Study acronym: RFA-CF-DM-ICMF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Diabetes mellitus (DM) is among the most common metabolic disorders globally. According to the data from international research, the number of persons with diabetes mellitus reached 366 million in 2011 and is predicted to increase to 552 million by 2030.
Trial Details
NCT Number NCT07139184
Lead Sponsor Assiut University
Conditions Charcot Foot
Enrollment 60 participants
Start Date 2025-10
Primary Completion 2026-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-24